AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
13.38
+0.30 (2.29%)
Apr 28, 2026, 4:00 PM EDT - Market closed
AdaptHealth Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for AdaptHealth stock have an average target of 13.5, with a low estimate of 12 and a high estimate of 15. The average target predicts an increase of 0.90% from the current stock price of 13.38.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AdaptHealth stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 3 | 3 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $13 → $14 | Strong Buy | Maintains | $13 → $14 | +4.63% | Apr 13, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $13 → $12 | Buy | Maintains | $13 → $12 | -10.31% | Feb 26, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $14 → $15 | Strong Buy | Maintains | $14 → $15 | +12.11% | Nov 6, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $14 → $13 | Strong Buy | Maintains | $14 → $13 | -2.84% | May 12, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $14 → $13 | Buy | Maintains | $14 → $13 | -2.84% | May 8, 2025 |
Financial Forecast
Revenue This Year
3.54B
from 3.24B
Increased by 9.00%
Revenue Next Year
3.78B
from 3.54B
Increased by 6.93%
EPS This Year
1.03
from -0.52
EPS Next Year
1.30
from 1.03
Increased by 25.73%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.7B | 4.0B | |
| Avg | 3.5B | 3.8B | |
| Low | 3.4B | 3.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 12.7% | 12.0% | |
| Avg | 9.0% | 6.9% | |
| Low | 3.9% | 1.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.24 | 1.51 | |
| Avg | 1.03 | 1.30 | |
| Low | 0.76 | 1.01 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 46.6% | |
| Avg | - | 25.7% | |
| Low | - | -2.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.